MAURA BRONDI: Open Payments
NPI 1528593423 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,274 in 56 payments from 12 companies in 2025. Trend: 2023 $415 · 2024 $460 · 2025 $1,274
Food & beverage: $1,274
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 38 | $616 |
| Medtronic, Inc. | 5 | $270 |
| Chiesi USA, Inc. | 1 | $130 |
| ABIOMED | 2 | $52 |
| PFIZER INC. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| Biosense Webster, Inc. | 1 | $33 |
| E.R. Squibb & Sons, L.L.C. | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
| BridgeBio Pharma, Inc. | 1 | $19 |
Products named: MICRA, KENGREAL, COREVALVE EVOLUT R, VYNDAQEL, VERQUVO, CARTO 3, ELIQUIS, OPSUMIT.
Industry payments across NY — which companies pay providers there.
